Oklahoma Heart Hospital
Oklahoma Heart Hospital
Oklahoma City, Oklahoma, United States18 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) | Acute Decompensated Heart Failure | Recruiting | Phase 3 | 2026-10-08 | NCT06898515 | |
| The ENCIRCLE Trial | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Active, not recruiting | Not applicable | 2026-10-06 | NCT04153292 | |
| A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Not applicable | 2026-09-25 | NCT07527299 | |
| A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05757869 | |
| REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not stated | 2026-09-24 | NCT06777368 | |
| Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation, persistent atrial fibrillation | Recruiting | Not stated | 2026-09-22 | NCT04088071 | |
| SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, kidney disorder, kidney failure, metabolic disease, urinary system disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-14 | NCT05198674 | |
| Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH) | Patient Satisfaction; Vascular Access Complication | Recruiting | Not applicable | 2026-08-19 | NCT04077762 | |
| Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction | Concentric Hypertrophy; Heart Failure With Preserved Ejection Fraction | Active, not recruiting | Not applicable | 2026-08-03 | NCT05839730 | |
| Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-05-22 | NCT05069558 | |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve disorder, mitral valve insufficiency | Recruiting | Not stated | 2026-05-07 | NCT04688190 | |
| A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) | Heart; Heart Failure With Preserved Ejection Fraction (HFPEF) | Recruiting | Phase 1 | 2026-04-09 | NCT07219511 | |
| Esprit BTK Post-Approval Study | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not applicable | 2026-03-25 | NCT06656364 | |
| RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial | Left Ventricle Remodeling, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Ventricular Remodeling, congestive heart failure | Recruiting | Not applicable | 2026-02-20 | NCT06813820 | |
| Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not stated | 2025-11-20 | NCT03970343 | |
| Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2025-07-20 | NCT02000115 | |
| Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2023-10-06 | NCT03108456 | |
| BioVentrix Revivent TC™ System Clinical Study | Ventricular Dysfunction, Ventricular Dysfunction, Left, cardiovascular disorder, heart disorder | Active, not recruiting | Not applicable | 2023-08-22 | NCT02931240 |